Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Frontiers in Oncology is Scopus-indexed (Q1, CiteScore 6.6), WoS SCIE, DOAJ. Published by Frontiers Media SA.
Checked against the index lists dated .
ISSN 2234-943XVerify ISSN ↗
Publisher: Frontiers Media SA
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 89 / 428 | 79th | Q1 |
| Cancer Research | 79 / 233 | 66th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q1, CiteScore 6.6.
Frontiers in Oncology is Q1 in Oncology (rank 89 of 428) and Q2 in Cancer Research (rank 79 of 233), by CiteScore 2025.
Frontiers in Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.6, which places it in quartile Q1 at the 79th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.020, quartile Q2, with an H-index of 173.
The publisher lists an article processing charge of about US$3,801 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Frontiers in Oncology is published by Frontiers Media SA. Its ISSN is 2234-943X.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Frontiers in Oncology has an h-index of 210 and a 2-year mean of 2.63 citations per paper (OpenAlex). Its Scopus CiteScore is 6.6, quartile Q1. On 2-year citations it ranks #141 of 424 Scopus journals in Oncology.
Frontiers in Oncology published 4,579 papers in 2025; its busiest recent year was 2022 with 7,655. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (66.5%), United States (10.7%) and Italy (2.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 203 retracted papers are recorded (5.2 per 1,000 papers). The Problematic Paper Screener flags 15 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.